Overview of Dr. Shin
Dr. Jacob Shin is a radiation oncologist in Middletown, NJ and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Monmouth, and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from Boston University School of Medicine and has been in practice 8 years. He is one of 106 doctors at Memorial Sloan Kettering Cancer Center and one of 8 doctors at Memorial Sloan Kettering Monmouth who specialize in Radiation Oncology. He has more than 40 publications and over 500 citings.
Office
480 Red Hill Road
Middletown, NJ 07748
Education & Training
Rush University Medical CenterResidency, Radiation Oncology, 2015 - 2019
Mount Auburn HospitalInternship, Preliminary Year, 2014 - 2015
Boston University School of MedicineClass of 2014
University of California, BerkeleyBA, Molecular and Cell Biology, 2002 - 2006
Certifications & Licensure
FL State Medical License 2023 - Present
CA State Medical License 2022 - 2026
NY State Medical License 2019 - 2026
NJ State Medical License 2019 - 2025
IL State Medical License 2015 - 2019
MA State Medical License 2014 - 2015- American Board of Radiology Radiation Oncology
Clinical Trials
- Reducing Acute Upper Gastrointestinal Side-Effects of Thoracic Irradiation Start of enrollment: 2022 Dec 13
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 167 citationsTrends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths.Stefanie Ueda, Daniel S. Kapp, Michael K. Cheung, Jacob Y. Shin, Kathryn Osann
American Journal of Obstetrics and Gynecology. 2008-02-01 - 14 citationsThe impact of race in male breast cancer treatment and outcome in the United States: a population-based analysis of 4,279 patients.Jacob Y. Shin, Lisa A. Kachnic, Ariel E. Hirsch
International Journal of Breast Cancer. 2014-10-02 - 330 citationsDo clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancersJohn K. Chan, Deanna Teoh, Jessica M. Hu, Jacob Y. Shin, Kathryn Osann
Gynecologic Oncology. 2008-06-01
Press Mentions
Insurers Eventually Approve Most Denials, Though Payer-Mandated Changes May Be Compromising CareJune 13th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
